BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 11345050)

  • 1. Ukrain: a novel antitumor drug.
    Uglyanitsa KN; Nefyodov LI; Doroshenko YM; Nowicky JW; Volchek IV; Brzosko WJ; Hodysh YJ
    Drugs Exp Clin Res; 2000; 26(5-6):341-56. PubMed ID: 11345050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway.
    Habermehl D; Kammerer B; Handrick R; Eldh T; Gruber C; Cordes N; Daniel PT; Plasswilm L; Bamberg M; Belka C; Jendrossek V
    BMC Cancer; 2006 Jan; 6():14. PubMed ID: 16417634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ukrain both as an anti cancer and immunoregulatory agent.
    Nowicky JW; Manolakis G; Meijer D; Vatanasapt V; Brzosko WJ
    Drugs Exp Clin Res; 1992; 18 Suppl():51-4. PubMed ID: 1305045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiomodification effects of Ukrain, a cytostatic and immunomodulating drug, on intracellular glucocorticoid reception during short-term gamma-irradiation.
    Luksa-Lichtenthaeler GL; Ladutko EI; Nowicky JW
    Drugs Exp Clin Res; 2000; 26(5-6):311-5. PubMed ID: 11345044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ukrain (NSC-631570) in experimental and clinical studies: a review.
    Jagiello-Wójtowicz E; Kleinrok Z; Urbanska EM
    Drugs Exp Clin Res; 1998; 24(5-6):213-9. PubMed ID: 10190077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies concerning the effect of Ukrain in vivo and in vitro.
    Brüller W
    Drugs Exp Clin Res; 1992; 18 Suppl():13-6. PubMed ID: 1305037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ukrain, an alkaloid thiophosphoric acid derivative of Chelidonium majus L. protects human fibroblasts but not human tumour cells in vitro against ionizing radiation.
    Cordes N; Plasswilm L; Bamberg M; Rodemann HP
    Int J Radiat Biol; 2002 Jan; 78(1):17-27. PubMed ID: 11747550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of macrophage tumouricidal activity by the alkaloid derivative Ukrain. In vitro and in vivo studies.
    Sotomayor EM; Rao K; Lopez DM; Liepins A
    Drugs Exp Clin Res; 1992; 18 Suppl():5-11. PubMed ID: 1305044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ukrain (NSC-631570) influences on bone status: a review.
    Jabłoński M
    Drugs Exp Clin Res; 2000; 26(5-6):317-20. PubMed ID: 11345045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Action of Ukrain, a cytostatic and immunomodulating drug, on effects of irradiation.
    Boyko VN; Voltchek IV; Petrov AS; Bubnov VP
    Drugs Exp Clin Res; 1996; 22(3-5):167-71. PubMed ID: 8899323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of apoptosis in cultured Chinese hamster ovary cells by Ukrain and its synergistic action with etoposide.
    Kurochkin SN; Kolobkov SL; Votrin II; Voltchek IV
    Drugs Exp Clin Res; 2000; 26(5-6):275-8. PubMed ID: 11345038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro effects of Chelidonium majus L. alkaloid thiophosphoric acid conjugates (Ukrain) on the phenotype of normal human lymphocytes.
    Slesak B; Nowicky JW; Harłozinska A
    Drugs Exp Clin Res; 1992; 18 Suppl():17-21. PubMed ID: 1305038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Ukrain on the activities of DNA-nicking enzymes.
    Votrin II; Voltchek IV; Kurochkin SN; Kolobkov SL
    Drugs Exp Clin Res; 2000; 26(5-6):267-73. PubMed ID: 11345037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ukrain(TM), a semisynthetic Chelidonium majus alkaloid derivative, acts by inhibition of tubulin polymerization in normal and malignant cell lines.
    Panzer A; Hamel E; Joubert AM; Bianchi PC; Seegers JC
    Cancer Lett; 2000 Nov; 160(2):149-57. PubMed ID: 11053644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent three-month treatment with Ukrain in intact and ovariectomized rats. Part III: Effect on the native electron paramagnetic resonance signal intensity of the femur.
    Jabłoński M; Korczak W; Gorzelak M; Jagiełło-Wójtowicz E
    Drugs Exp Clin Res; 2000; 26(5-6):333-6. PubMed ID: 11345048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent three-month treatment with Ukrain in intact and ovariectomized rats. Part II: Effect on bone mineral density of the femur.
    Jabłoński M; Gorzelak M; Patyra M; Jagiełło-Wójtowicz E
    Drugs Exp Clin Res; 2000; 26(5-6):327-31. PubMed ID: 11345047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chelidonium majus L. (Ukrain) in the treatment of cancer patients.
    Lohninger A; Hamler F
    Drugs Exp Clin Res; 1992; 18 Suppl():73-7. PubMed ID: 1305049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent three-month treatment with Ukrain in intact and ovariectomized rats. Part I: Effect on selected biomechanical parameters of the femur.
    Jabłoński M; Gorzelak M; Patyra M; Jagiełło-Wójtowicz E
    Drugs Exp Clin Res; 2000; 26(5-6):321-5. PubMed ID: 11345046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A method for determination of Ukrain in blood plasma for monitoring and pharmacokinetic study.
    Doroshenko YM; Hodysh YY; Uglyanitsa KN; Nefyodov LI
    Drugs Exp Clin Res; 2000; 26(5-6):163-70. PubMed ID: 11345023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro toxicity of Ukrain against human Ewing tumor cell lines.
    Lanvers-Kaminsky C; Nolting DM; Köster J; Schröder A; Sandkötter J; Boos J
    Anticancer Drugs; 2006 Oct; 17(9):1025-30. PubMed ID: 17001175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.